Combinatorial CRISPR screen identifies fitness effects of gene paralogues
Open Access
- 26 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-11
- https://doi.org/10.1038/s41467-021-21478-9
Abstract
Genetic redundancy has evolved as a way for human cells to survive the loss of genes that are single copy and essential in other organisms, but also allows tumours to survive despite having highly rearranged genomes. In this study we CRISPR screen 1191 gene pairs, including paralogues and known and predicted synthetic lethal interactions to identify 105 gene combinations whose co-disruption results in a loss of cellular fitness. 27 pairs influence fitness across multiple cell lines including the paralogues FAM50A/FAM50B, two genes of unknown function. Silencing of FAM50B occurs across a range of tumour types and in this context disruption of FAM50A reduces cellular fitness whilst promoting micronucleus formation and extensive perturbation of transcriptional programmes. Our studies reveal the fitness effects of FAM50A/FAM50B in cancer cells.Keywords
This publication has 49 references indexed in Scilit:
- Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersProceedings of the National Academy of Sciences of the United States of America, 2014
- Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for MelanomaMolecular Cancer Therapeutics, 2012
- Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding ProteinsCell, 2012
- Semiquantitative Proteomic Analysis of the Human Spliceosome via a Novel Two-Dimensional Gel Electrophoresis MethodMolecular and Cellular Biology, 2011
- Methylation screening of reciprocal genome-wide UPDs identifies novel human-specific imprinted genes†Human Molecular Genetics, 2011
- Synthetic lethality: General principles, utility and detection using genetic screens in human cellsFEBS Letters, 2010
- Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancerFrontiers in Bioscience-Landmark, 2009
- Isolation of an active step I spliceosome and composition of its RNP coreNature, 2008
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- A large-scale RNAi screen in human cells identifies new components of the p53 pathwayNature, 2004